Document Overview

Best Practices: 2009 Life Science Sales and Marketing IT Benchmark Guide


Author: Eric Newmark
Document #HI219601
PublishedAugust, 2009
Document TypeMarket Overview
Number of Pages     20

Overview

This Health Industry Insights report details IT spending expectations for 2009–2010 within the life science sales and marketing industry segment. Sales and marketing IT spend in the life sciences is expected to accelerate to a 7.9% growth rate during 2009.

Eric Newmark, research manager at Health Industry Insights, commented, "Securing face-to-face time with physicians, which was already challenging, has now become significantly more difficult for pharmaceutical sales. Regulations placing tight restrictions on promotional spend directed toward physicians are popping up in many states across the country at a very quick pace. Companies recognize they will soon need to shift their efforts for influencing physicians to different avenues, much of which will reside online. With most companies now experiencing double-digit increases in their online marketing spend, the pharmaceutical sales and marketing landscape is likely to look very different in a few years, with higher utilization of new technologies like social networking, or Web 2.0 platforms, and other emerging online mediums."

Health Industry Insights Opinion | In This Report | Situation Overview | Essential Guidance | Learn More
Subscriptions Covered:

Life Science Business Systems Strategy

Regions Covered:

Worldwide

Categories Covered:

Insights: Health Industry, Pharma

Our records show that you do not have access to this document.